Cellular Biomedicine Group Inc (CBMG) Return on Investment ROI from the third quarter of 2020 to third quarter of 2019 and for the year 2020, average high and low, overall ranking from Sep 30 2020 to Sep 30 2019 - CSIMarket
CSIMarket Company Name, Ticker, Suppliers, else..
 


• ROA Quarterly
• ROI Quarterly
• ROE Quarterly
Cellular Biomedicine Group Inc   (NASDAQ: CBMG)


Cellular Biomedicine Group Inc's ROI from its third quarter of 2020 to the third quarter of 2019 and 5 Year Period

Return on Investment, Quarterly Results, Trends, Rankings, Statistics

What is Cellular Biomedicine Group Inc's ROI in the third quarter of 2020?
Cellular Biomedicine Group Inc recorded a cumulative net loss of $-55 million during 12 months ending in the third quarter of 2020, resulting in a negative return on investment (ROI) of -100.14%.

Within the Healthcare sector 703 other companies had a higher return on investment. While return on investment, the total ranking has deteriorated compared to the second quarter of 2020 from 0 to 4324.

Definition and Formula of Return on Investment


Download as CSV
Commercial Data Licensing & OEM
Annual commercial subscriptions for corporate use, internal BI systems, management reporting, AI integration, and client-facing platforms
API & Data Feeds
Programmatic access to normalized fundamentals & ratios.

Return On Investment (Sep 30 2020)
III. Quarter		 (Jun 30 2020)
II. Quarter		 (Mar 31 2020)
I. Quarter		 (Dec 31 2019)
IV. Quarter		 (Sep 30 2019)
III. Quarter
Y / Y Investment Change TTM -40.39 % -31.8 % -14.44 % 5 % 18.27 %
Y / Y Net Income Change TTM - - - - -
Investment (TTM) in Millions 34 49 62 74 80
Return On Investment (TTM) -100.14 % -81.04 % -67.11 % -56.25 % -49.9 %
CBMG's Overall Ranking # 4324 # 0 # 0 # 0 # 0
Seq. Investment Change TTM -17.3 % -14.91 % -12.46 % -3.22 % -5.38 %
Seq. Net Income Change TTM - - - - -
Net Income (TTM) in Millions -55 -54 -52 -50 -46

CBMG Company Profile >> Back to CBMG Roi Comparisons >> See Annual CBMG Return On Investment



Return On Investment CBMG's Ranking
Within: No.
Industry # 97
Sector # 704
Overall # 4324

Return On Investment Statistics
High Average Low
864.05 %
-64.11 %
-1626.79 %
(Dec 31 2012)   (Sep 30 2012)







Financial Statements
Cellular Biomedicine Group Inc's III. Quarter Investments $ 34 Millions CBMG's Balance sheet
Cellular Biomedicine Group Inc's III. Quarter Income $ -17 Millions Quarterly CBMG's Income Statement
CBMG's Income by Division See CBMG's Income by Division


CBMG Annual Return On Investment (Dec 31 2019)
2019		 (Dec 31 2018)
2018		 (Dec 31 2017)
2017		 (Dec 31 2016)
2016		 (Dec 31 2015)
2015
Total Investments in Millions 74 85 57 66 46
Y / Y Investment Growth -13.83 % 48.69 % -13.25 % 42.68 % 17.25 %
Net Income in Millions -50 -39 -25 -28 -19
Y / Y Net Income Growth - - - - -
Annual Return On Investment -67.87 % -45.56 % -44.34 % -42.57 % -41.88 %


Annual Roi Comment


Definition and Formula of Return on Investment

Other ROI Ratios
Biotechnology & Pharmaceuticals Industry Roi Trends and Statistics
Healthcare Sector Return On Investment Statistics
Roi Trends for overall market
CBMG's Roi Ratio versus Biotechnology & Pharmaceuticals Industry, Healthcare Sector and total Market
Highest Ranking Return On Investment
Lowest Ranking Return On Investment
Subscribers only: Roi for CBMG's Competitors
Subscribers only: Roi for Cellular Biomedicine Group Inc's Suppliers
Subscribers only: Return On Investment for CBMG's Customers

Other Ratios
CBMG's Roa CBMG's Inventory Turnover Ratio CBMG's Growth Rates CBMG's Dividend Statistics
CBMG's Profitability Ratios CBMG's Asset Turnover Ratio CBMG's Dividend Growth
CBMG's Roe CBMG's Valuation Ratios CBMG's Financial Strength Ratios CBMG's Dividend Payout Ratio



Companies with similar Return On Investment at Sep 30 2020, within Healthcare Sector ROI

Date modified: 2026-09-08T15:10:05+00:00



Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.

© 2026 CSIMarket.com — Proprietary financial dataset. All rights reserved. Redistribution or automated extraction prohibited.